Our Sponsors

VIPCoFCCGBroadridgeLink Market Services GmbHAHEADhermesDP DHLK+SSAPGeorgesonSuedzuckerWacker Chemie AGThomson ReutersEQS Group

Search

VIPsight

Corporate Governance – portrayed in the individual cultural and legal framework, from the standpoint of equity capital.

VIPsight is a dynamic photo archive, sorted by nations and dates, by and for those interested in CG from all over the world.

VIPsight offers, every month:
transparent and independent current information / comments / facts and figures on corporate governance locally and internationally,

  • written by local CG experts,
  • selected and structured by the Club of Florence,
  • financed by its initiator VIP and other sponsors with a background of “Equity and Advisory” interests.
     

VIPsight International


Article Index

 

 

ACTIONS CORNER


Schering acquisition has a sequel for Bayer

The acquisition of Schering more than six years ago is to cost Bayer €300 million more. A ruling by the Berlin Regional Court in first instance says shareholders, who received €89.36 per share through the acquisition by the pharmaceutical and chemical company under the then control agreement, will now get €124.65, announced specialist corporate-law firm Dreier Riedel. In addition, the annual compensation was increased by €1.49 to €5.11. Moreover, the difference in the settlement must bear interest from 27 October 2006. By the decision of the Berlin Regional Court, Schering minority shareholders were confirmed in their legal opinion that they had been pushed out of the company far under value, said Peter Dreier. A Bayer spokesman said on 6 May the Group continues to hold the former payment appropriate. In addition, an opinion on the information had been rejected. A spokeswoman for the Berlin Regional Court was unwilling to comment on the proceedings.